Serious underlying medical conditions and COVID-19 vaccine hesitancy

Author:

Day DaphneORCID,Grech LisaORCID,Nguyen MikeORCID,Bain NathanORCID,Kwok AlastairORCID,Harris SamORCID,Chau HieuORCID,Chan BryanORCID,Blennerhassett RichardORCID,Nott LouiseORCID,Hamad NadaORCID,Tognela AnnetteORCID,Hoffman David,McCartney AmeliaORCID,Webber KateORCID,Wong JenniferORCID,Underhill CraigORCID,Sillars Brett,Winkel AntonyORCID,Savage MarkORCID,Loe Bao ShengORCID,Freeman DanielORCID,Segelov EvaORCID

Abstract

AbstractObjectiveTo examine vaccine uptake, hesitancy and explanatory factors amongst people with serious and/or chronic health conditions, including the impact of underlying disease on attitudes to vaccination.DesignCross-sectional survey.SettingTen Australian health services.Participants4683 patients (3560 cancer, 842 diabetes and 281 multiple sclerosis) receiving care at the health services participated in the 42-item survey, between June 30 to October 5, 2021.Main outcome measuresSociodemographic and disease-related characteristics, COVID-19 vaccine uptake, and the scores of three validated scales which measured vaccine hesitancy and vaccine-related beliefs generally and specific to the participants’ disease, including the Oxford COVID-19 Vaccine Hesitancy Scale, the Oxford COVID-19 Vaccine Confidence and Complacency Scale and the Disease Influenced Vaccine Acceptance Scale. Multivariable logistic regression was used to determine the associations between scale scores and vaccine uptake.ResultsOf all participants, 81.5% reported having at least one COVID-19 vaccine. Unvaccinated status was associated with younger age, female sex, lower education and income, English as a second language, and residence in regional areas (all p<0.05). Unvaccinated participants were more likely to report greater vaccine hesitancy and more negative perceptions toward vaccines (all p<0.05). Disease-related vaccine concerns were associated with unvaccinated status and hesitancy, including greater complacency about COVID-19 infection, and concerns relating to vaccine efficacy and impact on their disease and/or treatment (all p<0.05).ConclusionsDisease-specific concerns impact COVID-19 vaccine-related behaviours and beliefs in people with serious and/or chronic health conditions. This highlights the need to develop targeted strategies and education about COVID-19 vaccination to support medically vulnerable populations and health professionals.Trial registrationACTRN12621001467820

Publisher

Cold Spring Harbor Laboratory

Reference30 articles.

1. OECD. Health at a Glance 2021: OECD Indicators. Paris: OECD Publishing; 2021. Available from: https://www.oecd-ilibrary.org/sites/ae3016b9-en/index.html?itemId=/content/publication/ae3016b9-en (accessed March 10 2022).

2. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

3. WHO Strategic Advisory Group of Experts on Immunization. WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines. Geneva: World Health Organisation; 2022. Available from: https://apps.who.int/iris/bitstream/handle/10665/351138/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2022.1-eng.pdf?sequence=1&isAllowed=y (accessed March 10 2022).

4. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates

5. A global survey of potential acceptance of a COVID-19 vaccine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3